| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/08/2007 | CA2618050A1 Antibodies directed against an ldl receptor |
| 02/08/2007 | CA2617792A1 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/08/2007 | CA2617462A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617454A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617447A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617446A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617362A1 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 02/08/2007 | CA2617104A1 Amyloid beta receptor and uses thereof |
| 02/08/2007 | CA2617009A1 Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| 02/08/2007 | CA2616898A1 Cd33-specific single-chain immunotoxin and method of use |
| 02/08/2007 | CA2616588A1 Reagents for the detection of phosphorylated atr kinase (ser 428/ser 2317) and uses thereof |
| 02/08/2007 | CA2616026A1 Attenuated strains of flaviviruses , and uses thereof |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749885A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749839A1 Antigen binding polypeptides against F4(K88) fimbriae |
| 02/07/2007 | EP1749838A1 Interleukin-18-receptor proteins |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749835A2 Protective antigens and vaccines for the control of multi species tick infestations |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749537A1 Anti-idiotypics antibodies having a neutralising activity against factor VIII inhibitor antibody |
| 02/07/2007 | EP1749534A2 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749212A2 Diagnostic assay for trypanosoma cruzi infection |
| 02/07/2007 | EP1749031A2 Methods for reducing biofilm formation in infectious bacteria |
| 02/07/2007 | EP1749029A2 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 02/07/2007 | EP1749027A2 Gene products expressed differentially in tumors and use thereof |
| 02/07/2007 | EP1749024A2 Altered fibronectin-binding protein of staphylococcus aureus |
| 02/07/2007 | EP1748792A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/07/2007 | EP1748791A1 NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT |
| 02/07/2007 | EP1748790A2 Multi plasmid system for the production of influenza virus |
| 02/07/2007 | EP1748772A2 Combination therapies for cancer and proliferative angiopathies |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1311675B1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/07/2007 | EP1292333B1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 02/07/2007 | EP1200122B1 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 02/07/2007 | EP1194580B1 In vitro reconstitution of segmented negative-strand rna viruses |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP1126875B1 Dispensing device for a pharmaceutically active composition |
| 02/07/2007 | EP0948646B1 Methods for identifying genes essential to the growth of an organism |
| 02/07/2007 | EP0909272B1 Helicobacter pylori adhesin binding group antigen |
| 02/07/2007 | EP0870022B1 Immunostimulatory composition and method |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1910284A Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 02/07/2007 | CN1910276A Chimeric empty capsids of the infectious bursal disease virus (IBDV), obtainment process and applications |
| 02/07/2007 | CN1910200A Homogeneous preparations of IL-28 and IL-29 |
| 02/07/2007 | CN1910198A Tumor antigens for prevention and/or treatment of cancer |
| 02/07/2007 | CN1909925A Immunologic adjuvant |
| 02/07/2007 | CN1909924A Mucosal vaccine adjuvants containing bacterial flegellins as an active component |
| 02/07/2007 | CN1909923A Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 02/07/2007 | CN1909922A Novel flavivirus antigens |
| 02/07/2007 | CN1909921A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 02/07/2007 | CN1909920A Method for the delivery of sustained release agents |
| 02/07/2007 | CN1909918A T cell immunoreaction inhibitor |
| 02/07/2007 | CN1908170A Lim mineralization protein splice variants |
| 02/07/2007 | CN1908157A Yeast stain for preparing Pres-E1-E2 vaccine of hepatitis B and hepatitis C virus and preparation method thereof |
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/07/2007 | CN1907493A Ad5F35-LMP2 recombinant adenovirus vaccine comprising Epstein-Barr virus latent membrane protein 2 gene |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/07/2007 | CN1298848C Analog of haemophilus Hin47 with reduced protease activity |
| 02/07/2007 | CN1298845C Recombinant Newcastle disease LaSota low virulent vaccine strain expressing bird flu virus H5 subtype HA protein |
| 02/07/2007 | CN1298840C Bacilluscoli 0157 gene deficiency bacterin of intestinal hemorrhage |
| 02/07/2007 | CN1298738C Modified morbillivirus V proteins |
| 02/07/2007 | CN1298388C 单纯疱疹病毒ⅱ型dna疫苗 Herpes simplex virus type ⅱ dna vaccine |
| 02/07/2007 | CN1298387C Vaccine composition and stabilisation method |
| 02/07/2007 | CN1298385C Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 02/07/2007 | CN1298227C Effective sterilizing method capable of keeping colostrum immune globulin activity |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173116 Nucleic acid formulations for gene delivery and methods of use |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173010 Orphanin FQ receptor |
| 02/06/2007 | US7173002 Identifying modulator of transforming growth factor binding for use in treatment and prevention of abnormal wound healing and cell cell proliferative disorders |
| 02/06/2007 | US7172899 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172870 Treatment of papillomavirus infections |
| 02/06/2007 | US7172764 Rescue agents for treating botulinum toxin intoxications |
| 02/06/2007 | US7172763 Post-operative pain treatment by peripheral administration of a neurotoxin |
| 02/06/2007 | US7172762 For providing long-term protection against erysipelas in animals |
| 02/06/2007 | US7172761 Polyvalent immunogen |
| 02/06/2007 | US7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172758 Reducing occurrence of occlusions following treatment for arterial atherosclerotic disease; injecting into the blood-stream , prior to performing the angioplasty, a quantity of a bispecific antibody with two antigen binding sites |
| 02/06/2007 | US7172757 Method of treating fibroproliferative disorders |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/04/2007 | CA2551317A1 Anti-idiotypic antibody neutralizing the inhibitory action of an inhibitory antibody for factor viii |
| 02/03/2007 | CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 02/01/2007 | WO2007014335A2 Combinations comprising gemcitabine and tyrosine kinase inhibitors for the treatment of pancreatic cancer |
| 02/01/2007 | WO2007014311A2 Composition permitting muscle growth while protecting joint health |
| 02/01/2007 | WO2007014249A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 02/01/2007 | WO2007014247A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 02/01/2007 | WO2007014179A2 Method for controlling immunodominance |
| 02/01/2007 | WO2007014003A2 Systems and methods for delivery of a therapeutic agent |
| 02/01/2007 | WO2007013945A2 Treating disorders associated with inflammation |
| 02/01/2007 | WO2007013893A2 Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| 02/01/2007 | WO2007013794A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | WO2007013627A1 Therapeutic agent for b-lymphoma and hodgkin lymphoma |
| 02/01/2007 | WO2007013083A2 Complement c3a derived peptides and uses thereof |